NXEN (Nexien BioPharma) EPS (Diluted): $-0.00 (TTM As of Mar. 2025)


What is Nexien BioPharma EPS (Diluted)?

Nexien BioPharma NXEN EPS (Diluted) is $-0.00 as of Mar. 2025.

Nexien BioPharma's Earnings per Share (Diluted) for the three months ended in Mar. 2025 was $0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was $-0.00.

Nexien BioPharma's EPS (Basic) for the three months ended in Mar. 2025 was $0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 was $-0.00.

Nexien BioPharma's EPS without NRI for the three months ended in Mar. 2025 was $0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2025 was $-0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Nexien BioPharma  (OTCPK:NXEN) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Nexien BioPharma EPS (Diluted) Related Terms

Nexien BioPharma EPS (Diluted) Historical Data

* Premium members only.

The historical data trend for Nexien BioPharma's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nexien BioPharma EPS (Diluted) Chart

Nexien BioPharma Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EPS (Diluted)
Get a 7-Day Free Trial -0.05 -0.03 -0.01 -0.01 -0.00

Nexien BioPharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 -0.00 0.00 0.00 0.00

NXEN vs FLHLF, ZTS, UTHR: EPS (Diluted) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Nexien BioPharma's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nexien BioPharma PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nexien BioPharma's PE Ratio distribution charts can be found below:

* The bar in red indicates where Nexien BioPharma's PE Ratio falls into.


Nexien BioPharma EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Nexien BioPharma's Diluted EPS for the fiscal year that ended in Jun. 2024 is calculated as

Diluted EPS (A: Jun. 2024 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.239-0)/66.194
=-0.00

Nexien BioPharma's Diluted EPS for the quarter that ended in Mar. 2025 is calculated as

Diluted EPS (Q: Mar. 2025 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.03-0)/70.772
=-0.00

EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Diluted) →
What does a EPS (Diluted) of $-0.00 mean?
Nexien BioPharma (NXEN) has a EPS (Diluted) of $-0.00 as of Mar. 2025. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Nexien BioPharma and its competitors.
Is Nexien BioPharma's EPS (Diluted) too high?
Nexien BioPharma's current EPS (Diluted) is $-0.00.
How does Nexien BioPharma's EPS (Diluted) compare to FLHLF and ZTS?
Nexien BioPharma's EPS (Diluted) of $-0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Drug Manufacturers company?
A good EPS (Diluted) depends on the Drug Manufacturers industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Nexien BioPharma and its competitors. Nexien BioPharma's current EPS (Diluted) is $-0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nexien BioPharma stock overvalued right now?
Nexien BioPharma (NXEN) has a current EPS (Diluted) of $-0.00. The current EPS (Diluted) is $-0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For Nexien BioPharma (NXEN), the current EPS (Diluted) is $-0.00 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nexien BioPharma Business Description

Address 4340 East Kentucky Avenue, Suite 206, Glendale, CO, USA, 80246
Nexien BioPharma Inc is engaged in pre-clinical and drug development activities, by U.S. Food and Drug Administration (FDA) protocols, for certain pharmaceutical formulations that include cannabinoids. The company is pursuing the formulation and development of drugs containing cannabinoids for the treatment of various diseases, disorders, and medical conditions.